期刊文献+

糖皮质激素在小儿急性上呼吸道感染中应用的疗效及不良反应 被引量:6

The efficacy and adverse reactions of corticosteroids in treatment of children acute upper respiratory tract infection
暂未订购
导出
摘要 目的分析糖皮质激素在小儿急性上呼吸道感染中应用的疗效及不良反应。方法选择2009年8月~2010年8月我院收治的80例急性上呼吸道感染患儿,随机分为观察组与对照组各40例,观察组患儿接受糖皮质激素治疗,对照组患儿接受其他药物治疗,依照病情采取抗病毒药物或抗菌药物进行治疗,观察并分析患儿的退热时间、用药后的不良反应和并发症。结果观察组患儿与对照组相比表面体温下降,症状得到有效缓解(P<0.05),但不良反应严重,糖皮质激素延长了患儿的病程且使并发症增多,两组比较差异有统计学意义(P<0.05)。结论使用糖皮质激素治疗由急性上呼吸道感染引起的小儿发热弊大于利。 Objective To analyze the efficacy and adverse reactions of corticosteroids in treatment of children acute upper respiratory tract infection. Methods Eighty cases of children with acute upper respiratory tract infection in our hospital from August 2009 to August 2010 were choosed and ramdonly divided into observation group and control group with 40 cases in each. Patients of the observation group received corticosteroids therapy, and patients of the control group received other medication therapy, and fever clearance time, adverse drug reactions and complications of two groups were observed and analyzed. Results Compared with the control group, the surface temperature of the observation group declined, and symp- toms were effectively alleviated (P 〈 0.05) but adverse reactions were more serious, and glucocorticoids prolonged course of children and the complications increased (P 〈 0.05). Conclusion Treatment of children fever caused by acute upper respira- tory tract infection with glucocorticoids has more harm than good.
作者 刘慧
出处 《中国现代医生》 2012年第26期128-129,共2页 China Modern Doctor
关键词 糖皮质激素 急性上呼吸道感染 儿童 Corticosteroids Acute upper respiratory tract infection Children
  • 相关文献

参考文献5

二级参考文献35

  • 1Mudano A, Allison J, Hill J, et al. Variations in glucocorticoid induced osteoporosis prevention in a managed care cohort[J]. J Rheumatol, 2001,28 (6) : 1298-1305.
  • 2van Staa TP, Leufkens HG, Abenhaim L, et al. Use of oral corticosteroids and risk of fractures[J]. J Bone Miner Res,2000,15(6) :993-1000.
  • 3Praet JP,Peretz A,Rozenberg S,et al. Risk of osteoporosis in men with chronic bronchitis [J]. Osteoporos Int, 1992,2 (5) :257-261.
  • 4Iqbal F,Michaelson J, Thaler L, et aI. Declining bone mass in men with chronic pulmonary disease,contribution of glucocorticoid treatment, body mass index, and gonadal function[J]. Chest,1999,116(6) :1616-1624.
  • 5Takeda S, Elefteriou F, Levasseur R, et al. Leptin regulates bone formation via the sympathetic nervous system[J]. Cell,2002, 111 (3) : 305-317.
  • 6Aris RM, Renner JB, Winders AD, et al. Increased rate of fractures and severe kyphosis:sequelae of living into adulthood with cystic fibrosis [J ]. Ann Intern Med, 1998, 128 (3) : 186-193
  • 7Aris RM, Lester CE, Renner JB, et al. Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation [J]. Am J Respir Crit Care Med,2000,162(3) :941-946.
  • 8Barnard J, Newman LS. Sarcoidosis: immunology, rheumatic involvement,and therapeutics[J]. Curr Opin Rheumatol,2001,13(1) :84-91.
  • 9Laatikainen AK, Kroger HP, Tukiainen MO, et al. Bone mineral density in perimenopausal women with asthma:a population-based cross-sectional study[J]. Am J Respir Crit Care Med,1999,159(4):1179-1185.
  • 10Schlaich C, Minne HW, Bruckner T, et al. Reduced pulmonary function in patients with spinal osteoporotic fractures [J].Osteoporos Int, 1998,8(3) :261-267.

共引文献1202

同被引文献43

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部